Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

HLA-Matched Treg/Tcon Allogeneic Hematopoietic Cell Transplantation Is Safe and Ensures Remarkable Chronic GvHD/Leukemia Free Survival in High-Risk Leukemia Patients

Blood (2022) 140 (Supplement 1): 2133–2134.

https://doi.org/10.1182/blood-2022-169351

Published: 2022

Journal Articles

Acute GvHD after HLA-Haploidentical Hematopoietic Cell Transplantation with Regulatory and Conventional T Cell Immunotherapy Does Not Adversely Affect Transplantation Outcomes

Blood (2021) 138 (Supplement 1): 2885.

https://doi.org/10.1182/blood-2021-152839

Published: 2021

Journal Articles

Regulatory T Cell Adoptive Immunotherapy Promotes B Cell Immunity after Haploidentical Transplantation

Sara Piccinelli, Antonella Mancusi, PhD, Eni Hoxha, Loredana Ruggeri, MD, Franca Falzetti, MD, Alessandra Carotti, MD, Adelmo Terenzi, MD, Samanta Bonato, MD, Matteo Paradiso, MD, Tiziana Zei, Roberta Iacucci Ostini, Barbara Bigerna, Brunangelo Falini, MD PhD, Mauro Di Ianni, MD PhD, Massimo Fabrizio Martelli, MD, Andrea Velardi, MD, Antonio Pierini, MD PhD

Blood (2019) 134 (Supplement_1): 1917.

https://doi.org/10.1182/blood-2019-125715

Published: 2019

Journal Articles

Haploidentical Transplantation with Regulatory and Conventional T Cells Improves Outcome of Patients Affected By Acute Myeloid Leukemia with Complex Karyotype and/or Monosomy 7/Del(7q)

Blood (2018) 132 (Supplement 1): 2183.

https://doi.org/10.1182/blood-2018-99-116638

Published: 2018

Journal Articles

How Adoptive Immunotherapy with Conventional T and Regulatory T Cells Exerts a Gvl Effect without GvHD, after Haploidentical Hematopoietic Transplantation

Blood (2018) 132 (Supplement 1): 3333.

https://doi.org/10.1182/blood-2018-99-112512

Published: 2018

Journal Articles

Low-Toxicity/High-Efficacy HLA Haploidentical Transplantation for Elderly/Unfit Patients with Acute Leukemia

Andrea Velardi, MD, Alessandra Carotti, MD, Franca Falzetti, MD, Adelmo Terenzi, MD, Loredana Ruggeri, MD PhD, Antonio Pierini, MD PhD, Sara Piccinelli, MD, Sara Tricarico, MD, Amico Lucia, MD, Genni Casarola, MD, Valentina Lancillotta, MD, Simonetta Saldi, MD, Mauro Di Ianni, MD PhD, Cynthia Aristei, MD PhD, Massimo Fabrizio Martelli, MD PhD

Blood (2017) 130 (Supplement 1): 4601.

https://doi.org/10.1182/blood.V130.Suppl_1.4601.4601

Published: 2017

Journal Articles

An Accelerated CD8+, but Not CD4+, T-Cell Reconstitution Associates with a More Favorable Outcome Following HLA-Haploidentical HSCT: Results from a Retrospective Study of the Cell Therapy and Immunobiology Working Party of the EBMT

Blood (2015) 126 (23): 1929.

https://doi.org/10.1182/blood.V126.23.1929.1929

Published: 2015

Journal Articles

Haploidentical hematopoietic transplantation from KIR ligand–mismatched donors with activating KIRs reduces nonrelapse mortality

Antonella Mancusi, Loredana Ruggeri, Elena Urbani, Antonio Pierini, Maria Speranza Massei, Alessandra Carotti, Adelmo Terenzi, Franca Falzetti, Antonella Tosti, Fabiana Topini, Silvia Bozza, Luigina Romani, Rita Tognellini, Martin Stern, Franco Aversa, Massimo F. Martelli, Andrea Velardi

Blood (2015) 125 (20): 3173–3182.

https://doi.org/10.1182/blood-2014-09-599993

Published: 2015

Includes: Supplemental data

Journal Articles

Tregs Suppress GvHD at the Periphery and Unleash the Gvl Effect in the Bone Marrow

Loredana Ruggeri, Mauro Di Ianni, Elena Urbani, Antonella Mancusi, Franca Falzetti, Alessandra Carotti, Adelmo Terenzi, Maria Speranza Massei, Lucia Amico, Tiziana Zei, Roberta Iacucci, Massimo Fabrizio Martelli, Andrea Velardi

Blood (2014) 124 (21): 842.

https://doi.org/10.1182/blood.V124.21.842.842

Published: 2014

Journal Articles

HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse

Massimo F. Martelli, Mauro Di Ianni, Loredana Ruggeri, Franca Falzetti, Alessandra Carotti, Adelmo Terenzi, Antonio Pierini, Maria Speranza Massei, Lucia Amico, Elena Urbani, Beatrice Del Papa, Tiziana Zei, Roberta Iacucci Ostini, Debora Cecchini, Rita Tognellini, Yair Reisner, Franco Aversa, Brunangelo Falini, Andrea Velardi

Blood (2014) 124 (4): 638–644.

https://doi.org/10.1182/blood-2014-03-564401

Published: 2014

Journal Articles

“Designed” grafts for HLA-haploidentical stem cell transplantation

Massimo F. Martelli, Mauro Di Ianni, Loredana Ruggeri, Antonio Pierini, Franca Falzetti, Alessandra Carotti, Adelmo Terenzi, Yair Reisner, Franco Aversa, Brunangelo Falini, Andrea Velardi

Blood (2014) 123 (7): 967–973.

https://doi.org/10.1182/blood-2013-10-531764

Published: 2014

Journal Articles

HLA-Haploidentical Stem Cell Transplantation with Treg and Tcon Adoptive Immunotherapy promotes a Strong Graft-Versus-Leukemia Effect

Mauro Di Ianni, Loredana Ruggeri, Franca Falzetti, Alessandra Carotti, Adelmo Terenzi, Maria Speranza Massei, Lucia Amico, Antonio Pierini, Andrea Velardi, Massimo Fabrizio Martelli

Blood (2013) 122 (21): 907.

https://doi.org/10.1182/blood.V122.21.907.907

Published: 2013

Journal Articles

Decitabine In Advanced Chronic Myelomonocytic Leukemia

Valeria Santini, Bernardino Allione, Alessandro Levis, Daniela Gioia, Monia Lunghi, Antonella Poloni, Daniela Cilloni, Gina Zini, Alessandro Sanna, Alessia Rossi, Adelmo Terenzi, Emanuele Angelucci, Carlo Finelli, Francesco Onida, MD, Giuseppe Rossi, Dario Ferrero, MD, Giuseppe Saglio, Elisa Masiera

Blood (2013) 122 (21): 1573.

https://doi.org/10.1182/blood.V122.21.1573.1573

Published: 2013

Journal Articles

Adoptive Immunotherapy with Tregs and Tcons Ensures Low TRM and a Low Incidence of Post Transplant Leukaemia Relapse After HLA Haploidentical Transplants for Acute Leukemia

Mauro Di Ianni, Franca Falzetti, Alessandra Carotti, Adelmo Terenzi, Loredana Ruggeri, Pierini Antonio, Vincenza de Fazio, Valentina Zoi, Maria Speranza Massei, Yair Reisner, Andrea Velardi, Franco Aversa, Massimo Fabrizio Martelli, MD

Blood (2011) 118 (21): 154.

https://doi.org/10.1182/blood.V118.21.154.154

Published: 2011

Journal Articles

Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation

Blood (2011) 117 (14): 3921–3928.

https://doi.org/10.1182/blood-2010-10-311894

Published: 2011

Journal Articles

Quality of Life in Myelodysplastic Syndromes and Physicians' Perception.

Esther Natalie Oliva, MD, Valeria Santini, MD, Poloni Antonella, MD, Vincenzo Liso, MD, Daniela Cilloni, MD, Adelmo Terenzi, MD, Patrizia Guglielmo, MD, Riccardo Ghio, MD, Agostino Cortelezzi, MD, Giampietro Semenzato, MD, Cristina Clissa, MD, Flavia Salvi, MD, Oreste Villani, MD, Maria Antonietta Aloe Spiriti, MD

Blood (2009) 114 (22): 3822.

https://doi.org/10.1182/blood.V114.22.3822.3822

Published: 2009

Journal Articles

Adoptive Immunotherapy with Tregs Prevents GvHD and Favours Immune Reconstitution After HLA Haploidentical Transplants for Hematological Malignancies.

Mauro Di Ianni, Franca Falzetti, Alessandra Carotti, Adelmo Terenzi, Elisabetta Bonifacio, Yair Reisner, Andrea Velardi, Franco Aversa, Massimo F Martelli

Blood (2009) 114 (22): 4.

https://doi.org/10.1182/blood.V114.22.4.4

Published: 2009

Journal Articles

Quality of Life Assessment in Patients Affected by Myelodysplastic Syndrome

Esther Natali e Oliva, MD, Cristina Clissa, MD, Valeria Santini, Antonella Poloni, MD, Vincenzo Liso, MD, Daniela Cilloni, MD, PhD, Adelmo Terenzi, MD, Stefana Impera, MD, Alessandro Levis, MD, Agostino Cortelezzi, MD, Riccardo Ghio, MD, Giampietro Semenzato, MD, Oreste Villani, MD, Maria Antonietta Aloe Spiriti, MD

Blood (2008) 112 (11): 2363.

https://doi.org/10.1182/blood.V112.11.2363.2363

Published: 2008

Journal Articles

T Cell Pathway Deficiencies in Chronic Lymphocityc Leukemia: Partial Restoration with OKT3/IL-2 Activation.

Mauro Di Ianni, Lorenzo Moretti, Beatrice Del Papa, Maria De Ioanni, Adelmo Terenzi, Moira Bazzucchi, Raffaella Ciurnelli, Franca Falzetti, Antonio Tabilio

Blood (2007) 110 (11): 4692.

https://doi.org/10.1182/blood.V110.11.4692.4692

Published: 2007

Journal Articles

Hematopoietic Stem Cell Transplantation (HSCT) from Alternative Donors for Acute Leukemia at High-Risk of Relapse. The Haploidentical Option.

Franco Aversa, MD, Antonio Tabilio, MD, Adelmo Terenzi, MD, Stelvio Ballanti, MD, Alessandra Carotti, MD, Franca Falzetti, MD, Andrea Velardi, MD, Teresa Aloisi, MD, Leonardo Flenghi, MD, Jean Pierre Saab, MD, Yair M. Reisner, PhD, Massimo F. Martelli, MD

Blood (2005) 106 (11): 441.

https://doi.org/10.1182/blood.V106.11.441.441

Published: 2005

NARROW

HLA-Matched Treg/Tcon Allogeneic Hematopoietic Cell Transplantation Is Safe and Ensures Remarkable Chronic GvHD/Leukemia Free Survival in High-Risk Leukemia Patients

Acute GvHD after HLA-Haploidentical Hematopoietic Cell Transplantation with Regulatory and Conventional T Cell Immunotherapy Does Not Adversely Affect Transplantation Outcomes

Regulatory T Cell Adoptive Immunotherapy Promotes B Cell Immunity after Haploidentical Transplantation

Haploidentical Transplantation with Regulatory and Conventional T Cells Improves Outcome of Patients Affected By Acute Myeloid Leukemia with Complex Karyotype and/or Monosomy 7/Del(7q)

How Adoptive Immunotherapy with Conventional T and Regulatory T Cells Exerts a Gvl Effect without GvHD, after Haploidentical Hematopoietic Transplantation

Low-Toxicity/High-Efficacy HLA Haploidentical Transplantation for Elderly/Unfit Patients with Acute Leukemia

An Accelerated CD8+, but Not CD4+, T-Cell Reconstitution Associates with a More Favorable Outcome Following HLA-Haploidentical HSCT: Results from a Retrospective Study of the Cell Therapy and Immunobiology Working Party of the EBMT

Haploidentical hematopoietic transplantation from KIR ligand–mismatched donors with activating KIRs reduces nonrelapse mortality

Tregs Suppress GvHD at the Periphery and Unleash the Gvl Effect in the Bone Marrow

HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse

“Designed” grafts for HLA-haploidentical stem cell transplantation

HLA-Haploidentical Stem Cell Transplantation with Treg and Tcon Adoptive Immunotherapy promotes a Strong Graft-Versus-Leukemia Effect

Decitabine In Advanced Chronic Myelomonocytic Leukemia

Adoptive Immunotherapy with Tregs and Tcons Ensures Low TRM and a Low Incidence of Post Transplant Leukaemia Relapse After HLA Haploidentical Transplants for Acute Leukemia

Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation

Quality of Life in Myelodysplastic Syndromes and Physicians' Perception.

Adoptive Immunotherapy with Tregs Prevents GvHD and Favours Immune Reconstitution After HLA Haploidentical Transplants for Hematological Malignancies.

Quality of Life Assessment in Patients Affected by Myelodysplastic Syndrome

T Cell Pathway Deficiencies in Chronic Lymphocityc Leukemia: Partial Restoration with OKT3/IL-2 Activation.

Hematopoietic Stem Cell Transplantation (HSCT) from Alternative Donors for Acute Leukemia at High-Risk of Relapse. The Haploidentical Option.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only